HealthTwo cancer drugs from Li Ka-shing-backed Sequencio draw global attention
Two cancer vaccines developed by Hong Kong-based Sequencio Therapeutics have been selected for presentation at a major US conference. The company, a subsidiary of Li Ka-shing-backed CK Life Sciences, said it will present preclinical data on candidates CKLS118 and CKLS202 at the Society for Immunotherapy of Cancer meeting in Phoenix on Friday.
S
South China Morning Post★★☆☆☆2026-11-04 07:01Original
Two cancer drugs from Li Ka-shing-backed Sequencio draw global attention
Health